SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED

Autres langues Shandong Xinhua Pharmaceutical Company Limited

Actions

719 CNE100000411

Marché Fermé - Hong Kong S.E. Autres places de cotation 10:08:22 10/05/2024			Varia. 5j.	Varia. 1 janv.
5,78 ^HKD	+2,12%		+4,71%	0,00%

25/04	Shandong Xinhua Pharmaceutical Company Limited publie ses résultats pour le premier trimestre clos le 31 mars 2024	CI
11/04	Les capsules de céfaclor de l'unité de Xinhua Pharma passent l'évaluation réglementaire	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Xinhua Pharma Unit's Cefaclor Capsules Passes Regulatory Evaluation	11/04
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Supplementary Drug Application	08/04
Shandong Xinhua Pharmaceutical Posts Higher 2023 Profit	29/03
Shandong Xinhua Pharmaceutical Proposes New Auditor	29/03
Shandong Xinhua Pharmaceutical Company Limited Proposes Final Dividend for the Year Ended 31 December 2023	28/03
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Xinhua Pharma's Ibuprofen Gets Registration Approval in China	13/03
Shandong Xinhua Pharmaceutical Company Limited Receives Notification of Approval of Application for Marketing of Active Pharmaceutical Ingredient	28/02
Shandong Xinhua Pharmaceutical Company Limited Announces on Memantine Hydrochloride Tablets Obtaining the Drug Registration Certificate	19/01
Shandong Xinhua Pharmaceutical Company Limited Announces Executive Changes	25/12
Shandong Xinhua Pharmaceutical Gets Certificate for Registration of Levamlodiping Besylate Tablets	13/12
Shandong Xinhua Pharmaceutical Company Limited Receives Drug Registration Certificate of levamlodiping besylate tablets (2.5mg)	13/12
Respiratory Drug by Xinhua Pharmaceutical Unit Passes Regulatory Evaluation for Generic Drugs in China	04/12
Xinhua Pharmaceutical's Nine-Month Profit Jumps 34%	30/10/23
Shandong Xinhua Pharmaceutical Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	27/10/23
Shandong Xinhua Pharmaceutical’s AntiCoagulant Tablets Get Drug Registration Certificate	18/10/23
China Grants Marketing Approval for Shandong Xinhua Pharmaceutical's Uric Acid Medication; Shares Rise 4%	11/10/23
Shandong Xinhua Pharmaceutical Company Limited Announces Approval of Marketing Application for Chemical Raw Material Drugs for Drugsof Febuxostat	10/10/23
Xinhua Pharmaceutical Unit's Clarithromycin Granules Passes Regulatory Evaluation	20/09/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Shandong Xinhua Pharmaceutical Company Limited

Actions

719

CNE100000411

Autres langues

Filtres